1. Home
  2. CHOW vs HUMA Comparison

CHOW vs HUMA Comparison

Compare CHOW & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CHOW

ChowChow Cloud International Holdings Limited Ordinary Shares

N/A

Current Price

$0.65

Market Cap

227.1M

Sector

Technology

ML Signal

N/A

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$1.07

Market Cap

182.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CHOW
HUMA
Founded
2014
2004
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
227.1M
182.6M
IPO Year
2025
N/A

Fundamental Metrics

Financial Performance
Metric
CHOW
HUMA
Price
$0.65
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$10.00
AVG Volume (30 Days)
4.6M
5.4M
Earning Date
01-01-2026
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
38.82
N/A
EPS
0.07
N/A
Revenue
$33,343,904.00
$1,571,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$731.05
P/E Ratio
$9.81
N/A
Revenue Growth
73.74
N/A
52 Week Low
$0.57
$0.91
52 Week High
$21.91
$4.85

Technical Indicators

Market Signals
Indicator
CHOW
HUMA
Relative Strength Index (RSI) N/A 45.11
Support Level N/A $0.96
Resistance Level N/A $1.15
Average True Range (ATR) 0.00 0.09
MACD 0.00 0.00
Stochastic Oscillator 0.00 33.20

Price Performance

Historical Comparison
CHOW
HUMA

About CHOW ChowChow Cloud International Holdings Limited Ordinary Shares

ChowChow Cloud International Holdings Ltd is providing one-stop cloud solutions that support companies across the IT industry value chain throughout their entire cloud transformation journey from consulting, deployment and migration to cloud environment building and management. Its business comprises (i) digital transformation consulting services consisting of cloud suitability assessment (ii) professional IT services comprising of capabilities designed to facilitate seamless cloud integration and digital transformation, (iii) AI-powered proactive cloud managed services covering all aspects of day-to-day cloud maintenance and support, and (iv) IT infrastructure solutions covering on-premise private cloud setups and public cloud integrations including infrastructure applications.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: